Siragusa Thomas, CFO of Groove Botanicals (GROV), has demonstrated a consistent pattern of selling company stock without any offsetting purchases, according to SEC Form 4 filings. Over 40 reported transactions, all involving GROV, Thomas has sold shares totaling $32,136.16 while recording no buy activity. The most recent sales occurred on February 15, 2026, with six separate dispositions ranging from $170.24 to $4,342.64, followed by an earlier series of sales on November 17, 2025, with amounts between $144.06 and $3,658.83. These transactions, all coded as "F" for gifts or "M" for automatic securities dispositions, suggest a steady reduction in Thomas's position rather than a single concentrated exit.
The absence of any purchases alongside these sales indicates a clear directional bias toward divestment rather than accumulation. While the dollar amounts of individual transactions are relatively modest—none exceeding $5,000—the repeated nature of the sales over multiple dates points to an ongoing strategy rather than isolated liquidity events. The most recent filing on March 6, 2026, showed no monetary value, suggesting either a non-monetary transaction or a regulatory update without an accompanying trade. Thomas's activity remains exclusively tied to GROV, with no diversification into other securities evident in the filings.
AI-assisted summary